Page 8 - Pharma Industry
Sun Pharma to invest $25 million in Pharmazz Inc; raises stake to 22.7%
The company noted that the initial $10 million tranche, along with $7.5 million from the second SAFE tranche, will be invested by or before May 31, 2025
 "Sun Pharma to invest $25 million in Pharmazz Inc; raises stake to 22.7%")
Lupin to boost complex generics in US, EU; eyes chronic growth in India
Lupin plans to expand complex generics in developed markets and grow its chronic drug portfolio in India, with over 200 product launches and M&A on the radar
 "Lupin to boost complex generics in US, EU; eyes chronic growth in India")
Strong growth seen for Divi's Laboratories, but upside capped by valuations
Divi's posted a 12 per cent growth in revenues over the year-ago quarter. Although revenue growth has moderated after four consecutive quarters of top line growth in the 18-25 per cent range
 "Strong growth seen for Divi's Laboratories, but upside capped by valuations")
Sun Pharma gets USFDA approval for new device to treat skin disease
The company says that the new device is more compact and easier to use than its predecessor
JB Pharma Q4 results: Profit up 15% to ₹145.6 cr; revenue rises 10%
JB Pharma posts strong FY25 performance with 19.3% profit growth; domestic business up 20%, CDMO segment and Russia drive international gains
 "JB Pharma Q4 results: Profit up 15% to ₹145.6 cr; revenue rises 10%")
Margin pressures, growth triggers to weigh on Dr Reddy's Laboratories
The stock has been an underperformer compared to peers not only in the short term (three months, and six months) but also in the longer term
 "Margin pressures, growth triggers to weigh on Dr Reddy's Laboratories")
US President Donald Trump's drug price slash could sting Indian pharma
Up to 80% US price cuts may squeeze margins, push up innovator drug costs
 "US President Donald Trump's drug price slash could sting Indian pharma")
Trump's 'Make in America' push: Indian drug cos in no rush to make US shift
Pharma industry veteran said that the US wanting to encourage local production is a very natural thing to do
 "Trump's 'Make in America' push: Indian drug cos in no rush to make US shift")
Alembic Pharma Q4 profit dips 12%, revenue rises 17% to Rs 1,770 cr
India branded business grows 8% in Q4FY25 with 4 product launches while Ex-US markets rise 43% and US segment delivers 20% growth during the quarter
 "Alembic Pharma Q4 profit dips 12%, revenue rises 17% to Rs 1,770 cr")
Mutual Funds increased stake in 14 pharma stocks in Q4FY25; do you own any?
Analysts believe that pharma shares continue to see buying interest, given the inelastic demand for medicines; tariffs, if any could have minimal impact on the industry.
 "Mutual Funds increased stake in 14 pharma stocks in Q4FY25; do you own any?")
Indian pharma companies eye larger share of US cancer generics market
Indian firms have been focusing on complex generics for some time now, which insulates them partially from pricing pressures in the generics space in the US
 "Indian pharma companies eye larger share of US cancer generics market")
Trump tariff plan: US Prez to announce levy on pharma imports soon
The pharmaceutical sector was previously spared by the Trump administration in the last round of tariffs that were announced on April 2
 "Trump tariff plan: US Prez to announce levy on pharma imports soon")
Trump tariffs drags Sensex 300pts amid volatility; IT, pharma in focus
While the Nifty IT index lost 4.21 per cent due to US recession fears, investors found comfort in the pharma sector, which was spared harsh treatment in the sweeping tariffs announced by US President
 "Trump tariffs drags Sensex 300pts amid volatility; IT, pharma in focus")
Trump's 27% tariff on Indian exports: Who gains and who takes the hit?
The US Trump administration has levied a flat 27% tariff on Indian goods with some exemptions. Here how domestic players have been impacted
 "Trump's 27% tariff on Indian exports: Who gains and who takes the hit?")
Lupin announces acquisition of UK-Based Renascience Pharma for GBP 12.3 mn
Renascience, incorporated in 2015, supplies niche branded bio-generic products catering to primary and secondary care in the UK
 "Lupin announces acquisition of UK-Based Renascience Pharma for GBP 12.3 mn")
India may soon train select countries on best drug regulatory practices
The project will be an extension of the CDSCO and NIHFW's ongoing training programmes with drug inspectors from the central and state drug authorities
Bharat Biotech launches India's only integrated cell, gene therapy facility
BBIL's 50,000-square-foot CGT facility advances its mission to deliver life-saving treatments for haematological malignancies and inherited blood disorders
 "Bharat Biotech launches India's only integrated cell, gene therapy facility")
Key diabetes drug price crashes by up to 90% as generics enter market
Mankind, Alkem, Glenmark launch generic versions of empagliflozin
 "Key diabetes drug price crashes by up to 90% as generics enter market")
Emcure Pharmaceuticals share gains on foraying into daily supplements space
The uptick in the Emcure Pharmaceuticals share price came after the company announced its entry into the daily supplements space with the expansion of its Arth range
 "Emcure Pharmaceuticals share gains on foraying into daily supplements space")
Eliminate import duty on drugs from US: Pharma exporters to Centre
The exporters' worry is understandable as the US is the largest export market for Indian pharma accounting for 31.35 percent of India's overall pharma exports worth $27.8 bn
 "Eliminate import duty on drugs from US: Pharma exporters to Centre")